Priceline Pharmacy owner Australian Pharmaceutical Industries expects first-half earnings from its retail operations to fall because of store closures in Melbourne and parts of Sydney.

Chief executive Richard Vincent expects earnings to improve in the second half, which ends in August, barring any further enforced store closures, but said the strength of profit growth would likely depend on the rollout of the COVID-19 vaccine.